Global Youth Coalition on HIV/AIDS - Groups - Action Tools

Message

From:	Adeyemo Gabriel [ profile ]
Subject:	HIV/AIDS: Top 10 for 2010
Sent:	Jan 8th, 2011 - 13:29:45

	Date: 29 December 2010 Source: IRIN NewsPlus http://www.plusnews.org/Report.aspx?ReportId=91479 Fellow Advocate, This has been an exciting year for the fight against HIV, with dramatic developments in biomedical HIV prevention and a record five million people receiving life-prolonging treatment. It has also been a year fraught with funding difficulties and the continued discrimination against people living with HIV/AIDS and other marginalized groups. Here are the picks from PlusNews coverage: Microbicide breakthrough - After years of disappointing results, this year saw the first clinical evidence that a vaginal gel -- known as a microbicide -- could help to prevent sexual transmission of HIV. Such a preventative tool in the hands of women would radically reduce the level of new infections, analysts say. ARVs for prevention - A new study found that daily oral pre-exposure prophylaxis (PrEP) -- the use of ARVs to prevent HIV in high-risk groups -- reduced HIV infection risk among participants who took the ARV Truvada by an average 43.8 percent. Two-hour TB test - In December, the UN World Health Organization endorsed a new rapid test for TB that could potentially save millions of lives through earlier diagnosis. Treatment 2.0 - In July, UNAIDS launched a new approach to HIV treatment aimed at simultaneously achieving two holy grails of the AIDS response: drastic reductions in AIDS-related deaths and new HIV infections. "Treatment 2.0" aims to drastically scale up testing and treatment using current best practices and future innovations in antiretroviral (ARV) drugs and diagnostics, with the aim of averting 10 million deaths by 2025, and reducing new infections by one-third. Patent pool's first licence - In October, the US National Institutes of Health (NIH) became the first patent holder to join the recently created Medicines Patent Pool. By licensing the ARV Darunavir to the patent pool, it made the technology to produce it available for the benefit of low- and middle-income countries. UNITAID, the international health financing agency that established the pool, is optimistic many of the large pharmaceutical companies will soon follow the NIH by licensing their own patented ARVs. Easier travel - New rules allowing HIV-positive people to travel freely to the US came into effect early in 2010, ending a 22-year-old ban that had been widely criticized by AIDS activists as discriminatory and stigmatizing. China and Namibia also lifted HIV-related travel restrictions in 2010, but another 51 countries still have restrictions in place. Click on the above link to read the remaining article which includes; 7. Universal Access 8. Funding crisis 9. Anti-MSM sentiment 10. Threats to India's generics industry Thanks for reading through Yours' in Prevention Science, Adeyemo Gabriel Moderator: Students' for Microbicides (S4M), Nigeria

		Groups Powered by TakingITGlobal